How Much Does Mounjaro Cost Without Insurance?

Lilly lists Mounjaro at $1,112.16 per 28-day supply, but that is a list price—not a guaranteed pharmacy checkout price. If you have no insurance, ask for a cash quote for your exact prescription; pharmacy prices and available discounts can differ. Lilly’s Mounjaro pricing FAQ

Prices and program terms checked September 11, 2026. Manufacturer offers can change; confirm eligibility and the final pharmacy charge before purchasing.

“Uninsured” and “not covered” mean different things

Having no drug insurance is not the same as having a commercial plan that excludes Mounjaro. That distinction determines whether some advertised offers are even available to you.

Lilly’s current single-dose pen savings card lists a price as low as $499 for a 28-day fill when a patient has commercial drug insurance that does not cover Mounjaro. It is not an offer for people with no insurance. Eligibility also requires an FDA-labeled use, adulthood, US or Puerto Rico residency, and no government-funded coverage. Mounjaro savings-card terms

The noncovered commercial offer has savings limits of $647 per monthly fill and $8,411 per year, up to 13 fills, and expires December 31, 2026. The separate covered-commercial offer advertises as little as $25 for eligible fills, with different limits. Neither number should be presented as an unconditional uninsured price. Additional exclusions apply. Current card conditions

Before comparing two advertised prices, ask the provider which of these situations its number assumes. “Without coverage” can hide a commercial-insurance requirement that “without insurance” does not satisfy.

How to get a quote you can actually use

The published list price is a reference point, not a promise of what a patient will pay at a pharmacy. Lilly’s FAQ notes that the price a patient pays depends on their circumstances. Lilly’s Mounjaro pricing FAQ

Request quotes using the same prescription details each time:

Product and device: Mounjaro, with the specific presentation your clinician prescribed—not just “tirzepatide.”
Strength and quantity: the exact prescribed strength and a clearly stated day supply.
Payment method: ordinary cash price, a specific discount arrangement, or an approved insurance claim.
Final amount due: ask about any additional supplies or service charges and whether the quote depends on a first-fill promotion.

This is a comparison checklist, not an instruction to combine discounts. Ask the pharmacist which payment option can actually be used for your prescription, and save the quote with its date.

A 28-day supply is four weeks, not an average calendar month. When building a longer-term budget, count the refills your prescription requires rather than assuming twelve four-week fills cover a full year.

Mounjaro is not the weight-management brand

Mounjaro contains tirzepatide and has diabetes-related FDA-approved indications. Its current label includes blood-sugar management in adults and children aged 10 and older with type 2 diabetes, plus cardiovascular-risk reduction in specified high-risk adults with type 2 diabetes. It does not have a weight-management indication. Mounjaro prescribing information, revised August 2026

If weight management is the reason for your search, ask your clinician about treatments approved for that purpose. Zepbound is a separate tirzepatide brand with approved weight-management uses; its prescribing, device, and savings-program details are not interchangeable with Mounjaro’s. Zepbound prescribing information

A clinician may consider off-label treatment, but off-label use does not turn Mounjaro into an approved weight-loss product or establish savings-card eligibility. FDA explanation of off-label prescribing

If you are already using Mounjaro for diabetes and cannot afford a refill, contact your treating clinician about a continuity plan. Do not treat a weight-loss advertisement as a replacement plan for diabetes care or change treatment solely to match a price.

Comparing Gentle’s compounded tirzepatide

Gentle publishes compounded tirzepatide tiers starting at $169 monthly, increasing to $219 and $269 for higher prescribed dose ranges. Our tirzepatide monthly-cost guide shows the full tier table and included services.

That is a distinct compounded product, not Mounjaro at a discount. Compounded preparations are not FDA-approved and are not FDA-approved generic versions of the brand. Compounding does not confer the branded product’s FDA approval on the compounded preparation. FDA compounding overview

A cheaper quote alone does not establish that a compounded prescription is appropriate. The clinician must assess the medical need, and applicable compounding rules still govern the prescription and preparation. FDA specifically cautions against misleading promotional claims that compounded drugs are the same as approved products. FDA guidance on promoting compounded drugs

For a broader comparison of medication costs and the surrounding care, see our compounded GLP-1 program comparison. Compare only treatments your clinician considers suitable; this article does not promise that Gentle will replace diabetes treatment or prescribe branded Mounjaro.

Review safety before changing treatment

Mounjaro carries a boxed warning about thyroid C-cell tumors in rats and is contraindicated with a personal or family history of medullary thyroid carcinoma or MEN2. Gastrointestinal side effects and other serious risks need a clinician’s review, including interactions with your treatment plan. This price guide is not a complete safety summary. Mounjaro prescribing information

Frequently asked questions

Can I get the $499 Mounjaro offer if I am completely uninsured?

Not through the quoted commercial savings-card route: it requires commercial drug insurance even when that plan does not cover Mounjaro. Ask for a true uninsured cash quote instead.

Is the list price what every uninsured patient pays?

No. The pharmacy’s cash price and any available discount may differ. Get a current quote for the exact strength, device, quantity, and payment method.

Can I switch between Mounjaro, Zepbound, and compounded tirzepatide myself?

No. Shared drug terminology is not a self-directed substitution instruction. Ask your prescriber to assess the appropriate product, dose, and treatment plan before any change.

Sources

Dr. James Simmons, MD

Compounded medications are not FDA-approved. Treatment subject to medical evaluation.